{"title":"水性、粘性、空腔:原发性渗出性淋巴瘤","authors":"Anu Bajaj","doi":"10.31031/tteh.2018.01.000505","DOIUrl":null,"url":null,"abstract":"Primary effusion lymphoma (formerly known as body cavity lymphoma), is an infrequent, aggressive B cell non-Hodgkin’s lymphoma. The human herpes virus 8 (HHV8) or the Kaposi’s sarcoma associated herpes virus (KSHV) may be the potential determinant of the malignancy [1]. The viral genesis was determined in conjunction with the Kaposi’s sarcoma secondary to the human immune deficiency (HIV) virus and autoimmune deficiency syndrome (AIDS) in 1994 and to the non-Hodgkin’s lymphoma in 1995 [1,2]. Subsequently, the world health organization designated the primary effusion lymphoma as a singular, independent neoplasm in 2001 [3]. An estimated 4% of the HIV related non-Hodgkin’s lymphoma and 1% of the non-viralHIV related non-Hodgkin’s lymphoma may be constituted by PEL [4].","PeriodicalId":375686,"journal":{"name":"Trends in Telemedicine & E-health","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Aqueous, Glutinous, Cavitary: Primary Effusion Lymphoma\",\"authors\":\"Anu Bajaj\",\"doi\":\"10.31031/tteh.2018.01.000505\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Primary effusion lymphoma (formerly known as body cavity lymphoma), is an infrequent, aggressive B cell non-Hodgkin’s lymphoma. The human herpes virus 8 (HHV8) or the Kaposi’s sarcoma associated herpes virus (KSHV) may be the potential determinant of the malignancy [1]. The viral genesis was determined in conjunction with the Kaposi’s sarcoma secondary to the human immune deficiency (HIV) virus and autoimmune deficiency syndrome (AIDS) in 1994 and to the non-Hodgkin’s lymphoma in 1995 [1,2]. Subsequently, the world health organization designated the primary effusion lymphoma as a singular, independent neoplasm in 2001 [3]. An estimated 4% of the HIV related non-Hodgkin’s lymphoma and 1% of the non-viralHIV related non-Hodgkin’s lymphoma may be constituted by PEL [4].\",\"PeriodicalId\":375686,\"journal\":{\"name\":\"Trends in Telemedicine & E-health\",\"volume\":\"13 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Telemedicine & E-health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31031/tteh.2018.01.000505\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Telemedicine & E-health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31031/tteh.2018.01.000505","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Primary effusion lymphoma (formerly known as body cavity lymphoma), is an infrequent, aggressive B cell non-Hodgkin’s lymphoma. The human herpes virus 8 (HHV8) or the Kaposi’s sarcoma associated herpes virus (KSHV) may be the potential determinant of the malignancy [1]. The viral genesis was determined in conjunction with the Kaposi’s sarcoma secondary to the human immune deficiency (HIV) virus and autoimmune deficiency syndrome (AIDS) in 1994 and to the non-Hodgkin’s lymphoma in 1995 [1,2]. Subsequently, the world health organization designated the primary effusion lymphoma as a singular, independent neoplasm in 2001 [3]. An estimated 4% of the HIV related non-Hodgkin’s lymphoma and 1% of the non-viralHIV related non-Hodgkin’s lymphoma may be constituted by PEL [4].